Her scientific interests lie mostly in MPTP, Neurodegeneration, Substantia nigra, Dopaminergic and Dopamine. Her studies in MPTP integrate themes in fields like Neurotoxin, Biochemistry and Pharmacology. The study incorporates disciplines such as Immunology, Neuroscience and Parkinson's disease in addition to Neurodegeneration.
Her study in the field of LRRK2 is also linked to topics like Plant biology. As part of one scientific family, Vernice Jackson-Lewis deals mainly with the area of Substantia nigra, narrowing it down to issues related to the Neurotoxicity, and often Oxidative stress. Internal medicine and Endocrinology are the two main areas of interest in her Dopaminergic studies.
Her primary scientific interests are in Substantia nigra, MPTP, Internal medicine, Endocrinology and Dopamine. Her Substantia nigra study is concerned with the larger field of Neuroscience. Her study in Neuroscience is interdisciplinary in nature, drawing from both Disease and Microglia.
Her MPTP research incorporates elements of Neurotoxicity, Neurotoxin, Biochemistry and Neurodegeneration. Her study in the fields of Reserpine, Dopamine agonist and Oxidopamine under the domain of Endocrinology overlaps with other disciplines such as Peroxynitrite. Her studies examine the connections between Dopamine and genetics, as well as such issues in Homovanillic acid, with regards to Mitochondrial respiratory chain.
Vernice Jackson-Lewis mainly investigates Neuroscience, Parkinson's disease, Dopaminergic, MPTP and Substantia nigra. Neuroscience is closely attributed to Neurodegeneration in her research. Her Alpha-synuclein study in the realm of Parkinson's disease connects with subjects such as Genetically modified mouse.
Vernice Jackson-Lewis interconnects Glial cell line-derived neurotrophic factor, Neurochemical and Cholinergic neuron in the investigation of issues within Dopaminergic. Her work carried out in the field of MPTP brings together such families of science as Neurotrophic factors, Etiology and Tyrosine hydroxylase. Her Substantia nigra research is multidisciplinary, incorporating perspectives in Microgliosis and Cell biology.
Her primary areas of investigation include Neuroscience, Parkinson's disease, MPTP, Disease and Cell biology. Her work in Dopaminergic and Substantia nigra are all subfields of Neuroscience research. Her biological study spans a wide range of topics, including NADPH oxidase, Neuroinflammation and Microglia.
Her MPTP Poisoning study, which is part of a larger body of work in MPTP, is frequently linked to Extramural, bridging the gap between disciplines. Her Cell biology research incorporates themes from Astrocyte, Induced pluripotent stem cell and Fibroblast growth factor. Her Neurodegeneration study combines topics from a wide range of disciplines, such as Oxidative stress, Neurotoxicity, Pars compacta, Respiratory chain and Microgliosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Du Chu Wu;Vernice Jackson-Lewis;Miquel Vila;Kim Tieu.
The Journal of Neuroscience (2002)
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
G T Liberatore;V Jackson-Lewis;S Vukosavic;A S Mandir.
Nature Medicine (1999)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis;Serge Przedborski.
Nature Protocols (2007)
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.
Mingwei Li;Victor O. Ona;Christelle Guégan;Minghua Chen.
Science (2000)
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Serge Przedborski;Vernice Jackson-Lewis;Rina Yokoyama;Toshihiro Shibata.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Peter Teismann;Kim Tieu;Dong-Kug Choi;Du-Chu Wu.
Proceedings of the National Academy of Sciences of the United States of America (2003)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Du-Chu Wu;Peter Teismann;Kim Tieu;Miquel Vila.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.
William Dauer;Nikolai Kholodilov;Miquel Vila;Anne Cecile Trillat.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Vernice Jackson-Lewis;Michael Jakowec;Robert E Burke;Serge Przedborski.
Neurodegeneration (1995)
Oxidative stress and Parkinson’s disease
Javier Blesa;Ines Trigo-Damas;Anna Quiroga-Varela;Vernice R. Jackson-Lewis.
Frontiers in Neuroanatomy (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Columbia University
Columbia University
National Institute on Drug Abuse
Columbia University
Columbia University
Johns Hopkins University School of Medicine
Johns Hopkins University School of Medicine
Children's Hospital of Philadelphia
University of Ottawa
New York University
The Ohio State University
Blekinge Institute of Technology
Los Alamos National Laboratory
North Carolina State University
Rowan University
University of Georgia
Fred Hutchinson Cancer Research Center
Plymouth University
Washington University in St. Louis
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
J. Craig Venter Institute
University of California, Berkeley
Max Planck Society
University of California, Davis
University of California, Irvine
Battelle